A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 3, 2008, Pages 287-293

  Lowrance, David W ^a   Makombe, Simon ^b   Harries, Anthony D ^b,c,d   Shiraishi, Ray W ^a   Hochgesang, Mindy ^a   Aberle Grasse, John ^a   Libamba, Edwin ^b   Schouten, Erik ^a,e   Eilerbrock, Tedd ^a   Kamoto, Kelita ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTRY OF HEALTH   (Malawi)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e MANAGEMENT SCIENCES FOR HEALTH   (United States)

Author keywords

Antiretroviral treatment; National; Outcomes; Public health approach; Sub Saharan Africa; Survival

Indexed keywords

LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGRICULTURAL WORKER; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL DECISION MAKING; COHORT ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALAWI; MALE; MONITORING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; SCALE UP; SURVIVAL RATE; TREATMENT DURATION; AGED; MIDDLE AGED; MORTALITY; TIME; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; FEMALE; HUMANS; MALAWI; MALE; MIDDLE AGED; PUBLIC HEALTH; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149161237     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181893ef0     Document Type: Article

References (40)

1. National AIDS Commission. HIV and Syphilis Sero-Survey and National HIV Prevalence Estimates Report 2005. The Republic of Malawi, Africa: Ministry of Health; December 2005.
2. Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource poor settings. Lancet. 2006;367:1870-1872.
3. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505-510.
4. Libamba E, Makombe S, Harries AD, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes-the case of Malawi. Int J Tuberc Lung Dis. 2005;9:1062-1071.
5. Ministry of Health, Republic of Malawi. Human Resources in the Health Sector: Toward a Solution. Lilongwe, Malawi: Ministry of Health; 2004.
6. Harries AD, Gomani P, Teck R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg. 2004;98:695-701.
7. Harries AD, Libamba E, Schouten EJ, et al. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ. 2004;329:1163-1166.
8. Ministry of Health, Republic of Malawi. ART in the Public Sector in Malawi: Results up to 31st December 2007. Lilongwe, Malawi: Ministry of Health; 2008.
9. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district in Malawi: an effectiveness assessment. Lancet. 2006;367:1335-1342.
10. Ministry of Health, Republic of Malawi. Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi. 2nd ed. Lilongwe, Malawi: Ministry of Health; 2006.
11. World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access. Geneva, Switzerland: World Health Organization; 2006.
12. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007; 4(10):e298. doi:10.1371/journal.pmed.0040298.
13. The Glimmix Procedure, November 2005. Available at: http://support.sas. com/rnd/app/papers/glimmix.pdf. Accessed April 24, 2007.
14. Chiang CL. Medical follow-up studies. In: The Life Table and Its Applications. Malabar, FL: Robert E. Krieger; 1984:221-244.
15. Report on the Global AIDS Epidemic 2006. Geneva, Switzerland: The Joint United Nations Programme on HIV/AIDS; 2006.
16. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006;20:41-48.
17. Stringer JSA, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia. JAMA. 2006;296:782-793.
18. ART-LINC Collaboration and ART Cohort Collaboration Groups. Mortality of HIV-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
19. Severe P, Leger P, Macarthur C, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. A' Engl J Med. 2005;353:2325-2334.
20. Madec Y, Laureillard D, Pinoges L, et al. Response to highly active antiretroviral therapy among severely immuno-compromised HIVinfected patients in Cambodia. AIDS. 2007;21:351-359.
21. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two year of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.
22. O'Brien DP, Saufageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.
23. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr. 2006;43:418-425.
24. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral treatment who are lost to follow-up in Malawi. Bull World Health Organ. 2007;85:550-554.
25. van Oosterhout J, Laufer M, Graham S, et al. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV J Acquir Immune Defic Svndr. 2005;39: 626-631.
26. Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371:1603-1611.
27. Harries AD, Schouten EJ, Makombe SD, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ. 2007;85:152-155.
28. Kamoto K, Aberle-Grasse J, et al. Malawi HIV Drug Resistance Threshold Baseline Survey Results. Antiviral Therapy. 2008;Suppl 2: 69-75.
29. Montaner JSG, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531-536.
30. Lawn SD, Myer L, Orrell C, et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005;19:2141-2148.
31. Lowrance D, Filler S, Makombe S, et al. Assessment of a national monitoring and evaluation for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007;12:377-381.
32. Makombe SD, Hochgesang M, Jahn A, et al. Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ. 2008;86:310-314.
33. Boerma JT, Stanecki KA, Newell M-L, et al. Monitoring of scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Oigan. 2006;84:145-150.
34. Ministry of Health, Republic of Malawi. Cotrimoxazole Preventive Therapy for HIV-Positive Persons in Malawi. Lilongwe, Malawi: Ministry of Health; 2006.
35. Mermin J, Ekwaru JP, Liechty CA, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bed nets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet. 2006;367:1256-1261.
36. Lowrance D, Makombe S, Harries AD, et al. Lower early mortality rates among patients receiving antiretroviral treatment at clinics providing cotrimoxazole prophylaxis in Malawi. J Acquir Immune Defic Syndr. 2007;46:56-61.
37. Hawley WA, Phillips-Howard PA, ter Kuile FO, et al. Community-wide effects of permethrin-treated bednets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg. 2003;68(Suppl): 121-127.
38. Makombe S, Jahn A, Tweya H, et al. A national survey of the impact of national scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ. 2007;85:851-857.
39. Ministry of Health, Republic of Malawi. Triangulation Workshop: Findings, Conclusions, and Recommendations. Lilongwe, Malawi: Ministry of Health; 2006.
40. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;46: 855-858.